A Study Using Radiation Therapy and Temozolomide to Treat Glioblastoma in Patients Over 70
Status:
Recruiting
Trial end date:
2025-05-01
Target enrollment:
Participant gender:
Summary
In this study we propose to determine outcomes of patients age 70 or older treated with
radiation over 2 weeks given with temozolomide 75 mg/m2 daily during radiotherapy and as a
post radiation treatment of 150 mg/m2 - 200 mg /m2 for 6 cycles or until the disease
progresses.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
James Graham Brown Cancer Center University of Louisville
Collaborators:
James Graham Brown Cancer Center University of Louisville